NCT01944462

Impact and Cost of a Pharmacist Pneumococcal Vaccination Program With PNEUMOVAX® 23 at an Urban Senior Center

Impact and Cost of a Pharmacist Pneumococcal Vaccination Program With PNEUMOVAX® 23 at an Urban Senior Center for Adults Aged 65 Years or Older or Those With Defined Risk Factors for Invasive Pneumococcal Disease

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 203 (actual)
• Sponsor: Thomas Jefferson University · Academic / Other
• Sex: All
• Age: 50 Years
• Healthy volunteers: Accepted

Summary

The overall goals of this program are to measure the impact of a pharmacist pneumococcal vaccine education program (PPVP) using a senior center model of care and provide the pneumococcal vaccine to eligible participants. Hypotheses 1. PPVP will result in improved knowledge and awareness in older minorities in the senior center setting (primary hypothesis); 2. Participants who are vaccinated through the project will experienced increased trust in receiving vaccines from a pharmacist; 3. Participants will be satisfied with and trust the PV information provided by pharmacists in the PPVP; 4. PPVP is an efficient approach to educating patients in the senior center based on its costs; 5. Participating pharmacists will be activated to implement PPVP learnings in their practice.

Conditions

• Study is Open to Seniors Age 50 or Older

Interventions

Type	Name	Description
BEHAVIORAL	Pharmacist Pneumococcal Vaccine Program (PPVP)	1.5 hour educational intervention delivered onsite at collaborating senior center consisting of 3 components: presentation about pneumococcal disease and the vaccine given by a infectious disease-certified pharmacist; 2) skits given by volunteer actors at the senior center to illustrate real world scenarios related to pneumococcal disease and the vaccine; 3) action planning to consist of small group breakouts led by licensed pharmacists and 4) vaccination day which is an optional component following the education program, for participants eligible to receive the vaccine. Vaccination to be provided free of charge to eligible participants who opt to receive it.

Timeline

• Start date: 2014-01-01
• Primary completion: 2014-11-01
• Completion: 2014-11-01
• First posted: 2013-09-17
• Last updated: 2018-01-03
• Results posted: 2018-01-03

Locations

1 site across 1 country: United States